High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma

References

• Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hypopharynx and larynx: report of 10 cases. Hum Pathol 1986; 17: 1158–66
   PubMed Web of Science ®Google Scholar
• World Health Organization. Histological typing of tumours of the upper respiratory tract and ear. Springer-Verlag, BerlinGermany 1991
   Google Scholar
• Ferlito A, Altavilla G, Rinaldo A, Doglioni C. Basaloid squamous cell carcinoma of the larynx and hypopharynx. Ann Otol Rhinol Laryngol 1997; 106: 1024–35
   PubMed Web of Science ®Google Scholar
• Bahar G, Feinmesser R, Popovtzer A, Ulanovsky D, Nageris B, Marshak G, et al. Basaloid squamous carcinoma of the larynx. Am J Otolaryngol 2003; 24: 204–8
   PubMed Web of Science ®Google Scholar
• Erisen LM, Coskun H, Ozuysal S, Basut O, Onart S, Hizalan I, et al. Basaloid squamous cell carcinoma of the larynx: a report of four new cases. Laryngoscope 2004; 114: 1179–83
   PubMed Web of Science ®Google Scholar
• Zbaren P, Nuyens M, Stauffer E. Basaloid squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 116–21
   PubMedGoogle Scholar
• De Sampaio Goes FC, Oliveira DT, Dorta RG, Nishimoto IN, Landman G, Kowalski LP. Prognoses of oral basaloid squamous cell carcinoma and squamous cell carcinoma: a comparison. Arch Otolaryngol Head Neck Surg 2004; 130: 83–6
   PubMedGoogle Scholar
• Banks ER, Frierson HF, Mills SE, George E, Zarbo RJ, Swanson PE. Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol 1992; 16: 935–46
   Web of Science ®Google Scholar
• Chao J-I, Kuo P-C, Hsu T-S. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. J Biol Chem 2004; 279: 20267–76
   PubMed Web of Science ®Google Scholar
• Nemoto T, Kitagawa M, Hasegawa M, Ikeda S, Akashi T, Takizawa T, et al. Expression of IAP family proteins in esophageal cancer. Exp Mol Pathol 2004; 76: 253–9
   PubMed Web of Science ®Google Scholar
• Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581–9
   PubMed Web of Science ®Google Scholar
• International Union Against Cancer. TNM classification of malignant tumours5th ed. Wiley-Liss, New York 1997
   Google Scholar
• Kleist B, Bankau A, Lorenz G, Jager B, Poetsch M. Different risk factors in basaloid and common squamous head and neck cancer. Laryngoscope 2004; 114: 1063–8
   PubMed Web of Science ®Google Scholar
• Poetsch M, Lorenz G, Bankau A, Kleist B. Basaloid in contrast to non-basaloid head and neck squamous cell carcinomas display aberrations especially in cell cycle control genes. Head Neck 2003; 25: 904–10
   PubMed Web of Science ®Google Scholar
• Marioni G, Gaio E, Giacomelli L, Marchese-Ragona R, Staffieri C, Staffieri A, et al. Endoglin (CD105) expression in basaloid squamous cell carcinoma of head and neck. Acta Otolaryngol 2005; 125: 307–11
   PubMed Web of Science ®Google Scholar
• Lo Muzio L, Campisi G, Giovannelli L, Ammatuna P, Greco I, Staibano S, et al. HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship?. Oral Oncol 2004; 40: 736–41
   PubMed Web of Science ®Google Scholar
• Weinman EC, Roche PC, Kasperbauer JL, Cha SS, Sargent DJ, Cheville J, et al. Characterization of antigen processing machinery and survivin expression in tonsillar squamous cell carcinoma. Cancer 2003; 97: 2203–11
   PubMed Web of Science ®Google Scholar
• Grabowski P, Kühnel T, Mühr-Wilkenshoff, Heine B, Stein H, Hüpfner M, et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 2003; 88: 115–9
   PubMed Web of Science ®Google Scholar
• Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res 2002; 22: 2377–83
   PubMed Web of Science ®Google Scholar
• Pizem J, Cör A, Gale N. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology 2004; 45: 180–6
   PubMed Web of Science ®Google Scholar
• Sharma H, Sen S, Mathur M, Bahadur S, Singh N. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Head Neck 2004; 26: 733–40
   PubMed Web of Science ®Google Scholar
• Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggio MA, et al. Survivin expression in oral squamous cell carcinoma. Br J Cancer 2003; 89: 2244–8
   PubMed Web of Science ®Google Scholar
• Li F, Yang J, Ramnath N, Javle MM, Tan D. Nuclear or cytoplasmic expression of survivin: what is the significance?. Int J Cancer 2005; 114: 509–12
   PubMed Web of Science ®Google Scholar
• Meng H, Lu C, Mabuchi H, Tanigawa N. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Lett 2004; 216: 147–55
   PubMed Web of Science ®Google Scholar